These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 26174121)

  • 21. Absorption and release of protein from hydroxyapatite-polylactic acid (HA-PLA) membranes.
    Talal A; Waheed N; Al-Masri M; McKay IJ; Tanner KE; Hughes FJ
    J Dent; 2009 Nov; 37(11):820-6. PubMed ID: 19631440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of hydroxyapatite-ciprofloxacin bone-implants using "Quality by design".
    Nayak AK; Laha B; Sen KK
    Acta Pharm; 2011 Mar; 61(1):25-36. PubMed ID: 21406341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Porous hydroxyapatite scaffold with three-dimensional localized drug delivery system using biodegradable microspheres.
    Son JS; Appleford M; Ong JL; Wenke JC; Kim JM; Choi SH; Oh DS
    J Control Release; 2011 Jul; 153(2):133-40. PubMed ID: 21420453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SEM and TEM for structure and properties characterization of bacterial cellulose/hydroxyapatite composites.
    Arkharova NA; Suvorova EI; Severin AV; Khripunov AK; Krasheninnikov SV; Klechkovskaya VV
    Scanning; 2016 Nov; 38(6):757-765. PubMed ID: 27171920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PCL-coated hydroxyapatite scaffold derived from cuttlefish bone: morphology, mechanical properties and bioactivity.
    Milovac D; Gallego Ferrer G; Ivankovic M; Ivankovic H
    Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():437-45. PubMed ID: 24268280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlled drug delivery from composites of nanostructured porous silicon and poly(L-lactide).
    McInnes SJ; Irani Y; Williams KA; Voelcker NH
    Nanomedicine (Lond); 2012 Jul; 7(7):995-1016. PubMed ID: 22394185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Addition of MgO nanoparticles and plasma surface treatment of three-dimensional printed polycaprolactone/hydroxyapatite scaffolds for improving bone regeneration.
    Roh HS; Lee CM; Hwang YH; Kook MS; Yang SW; Lee D; Kim BH
    Mater Sci Eng C Mater Biol Appl; 2017 May; 74():525-535. PubMed ID: 28254327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation of hybrid materials for controlled drug release.
    Milczewska K; Voelkel A; Zwolińska J; Jędro D
    Drug Dev Ind Pharm; 2016; 42(7):1058-65. PubMed ID: 26559181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bisphosphonates: the first 40 years.
    Russell RG
    Bone; 2011 Jul; 49(1):2-19. PubMed ID: 21555003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and characterization of hydroxyapatite-ciprofloxacin delivery systems by precipitation and spray drying technique.
    Pham HH; Luo P; Génin F; Dash AK
    AAPS PharmSciTech; 2002; 3(1):E1. PubMed ID: 12916954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite.
    Nancollas GH; Tang R; Phipps RJ; Henneman Z; Gulde S; Wu W; Mangood A; Russell RG; Ebetino FH
    Bone; 2006 May; 38(5):617-27. PubMed ID: 16046206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A collagen-hydroxyapatite scaffold allows for binding and co-delivery of recombinant bone morphogenetic proteins and bisphosphonates.
    Murphy CM; Schindeler A; Gleeson JP; Yu NY; Cantrill LC; Mikulec K; Peacock L; O'Brien FJ; Little DG
    Acta Biomater; 2014 May; 10(5):2250-8. PubMed ID: 24456759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Encapsulation of anticancer drug copper bis(8-hydroxyquinoline) in hydroxyapatite for pH-sensitive targeted delivery and slow release.
    Weerasuriya DRK; Wijesinghe WPSL; Rajapakse RMG
    Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():206-213. PubMed ID: 27987700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RGD-conjugated copolymer incorporated into composite of poly(lactide-co-glycotide) and poly(L-lactide)-grafted nanohydroxyapatite for bone tissue engineering.
    Zhang P; Wu H; Wu H; Lù Z; Deng C; Hong Z; Jing X; Chen X
    Biomacromolecules; 2011 Jul; 12(7):2667-80. PubMed ID: 21604718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [In vitro biologic evaluation on nano-hydroxyapatite/poly (L-lactic acid) biocomposites fabricated using in-situ growth method].
    Zhang C; Feng Q; Zhang T; Chen J; Lu C; Wu H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Apr; 29(2):307-10. PubMed ID: 22616180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sol-gel derived terbium-containing mesoporous bioactive glasses nanospheres: In vitro hydroxyapatite formation and drug delivery.
    Wang X; Zhang Y; Lin C; Zhong W
    Colloids Surf B Biointerfaces; 2017 Dec; 160():406-415. PubMed ID: 28965080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bisphosphonates enhance bacterial adhesion and biofilm formation on bone hydroxyapatite.
    Kos M; Junka A; Smutnicka D; Szymczyk P; Gluza K; Bartoszewicz M
    J Craniomaxillofac Surg; 2015 Jul; 43(6):863-9. PubMed ID: 26027867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. pH responsive controlled release of anti-cancer hydrophobic drugs from sodium alginate and hydroxyapatite bi-coated iron oxide nanoparticles.
    Manatunga DC; de Silva RM; de Silva KMN; de Silva N; Bhandari S; Yap YK; Costha NP
    Eur J Pharm Biopharm; 2017 Aug; 117():29-38. PubMed ID: 28330763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative appraisal of clodronate, aspirin and dexamethasone as agents reducing alendronate-induced inflammation in a murine model.
    Yu Z; Funayama H; Deng X; Kuroishi T; Sasano T; Sugawara S; Endo Y
    Basic Clin Pharmacol Toxicol; 2005 Oct; 97(4):222-9. PubMed ID: 16176557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BMP-2 release and dose-response studies in hydroxyapatite and beta-tricalcium phosphate.
    Tazaki J; Murata M; Akazawa T; Yamamoto M; Ito K; Arisue M; Shibata T; Tabata Y
    Biomed Mater Eng; 2009; 19(2-3):141-6. PubMed ID: 19581707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.